Controversies And Cutting Edge | Priapism

<< Emergency Department Management of Priapism (Pharmacology CME)

Controversies And Cutting Edge

There is a lack of evidence substantiating novel therapies for the treatment of ischemic priapism. Most data are confined to case reports or limited studies. For example, intracavernosal methylene blue has been shown as a potential therapy for ischemic priapism in 2 studies,66,67 but, to our knowledge, no comparative studies between methylene blue and phenylephrine exist. In a case report, a 4 mg/kg intramuscular dose of ketamine was used to treat priapism caused by dexmethylphenidate in a pediatric patient.68

To continue reading, please log in or purchase access.

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Get A Sample Issue Of Emergency Medicine Practice
Enter your email to get your copy today! Plus receive updates on EB Medicine every month.
Please provide a valid email address.